Literature DB >> 15081130

Spinal tumors.

J W M Van Goethem1, L van den Hauwe, O Ozsarlak, A M A De Schepper, P M Parizel.   

Abstract

Spinal tumors are uncommon lesions but may cause significant morbidity in terms of limb dysfunction. In establishing the differential diagnosis for a spinal lesion, location is the most important feature, but the clinical presentation and the patient's age and gender are also important. Magnetic resonance (MR) imaging plays a central role in the imaging of spinal tumors, easily allowing tumors to be classified as extradural, intradural-extramedullary or intramedullary, which is very useful in tumor characterization. In the evaluation of lesions of the osseous spine both computed tomography (CT) and MR are important. We describe the most common spinal tumors in detail. In general, extradural lesions are the most common with metastasis being the most frequent. Intradural tumors are rare, and the majority is extramedullary, with meningiomas and nerve sheath tumors being the most frequent. Intramedullary tumors are uncommon spinal tumors. Astrocytomas and ependymomas comprise the majority of the intramedullary tumors. The most important tumors are documented with appropriate high quality CT or MR images and the characteristics of these tumors are also summarized in a comprehensive table. Finally we illustrate the use of the new World Health Organization (WHO) classification of neoplasms affecting the central nervous system.

Entities:  

Mesh:

Year:  2004        PMID: 15081130     DOI: 10.1016/j.ejrad.2003.10.021

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  35 in total

Review 1.  Intradural spinal tumors: current classification and MRI features.

Authors:  Kasim Abul-Kasim; Majda M Thurnher; Paul McKeever; Pia C Sundgren
Journal:  Neuroradiology       Date:  2007-12-15       Impact factor: 2.804

2.  Differentiating malignant vertebral tumours from non-malignancies with CT spectral imaging: a preliminary study.

Authors:  Yuan Yuan; Yan Zhang; Ning Lang; Jianying Li; Huishu Yuan
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

Review 3.  An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.

Authors:  Mojdeh Safari; Alireza Khoshnevisan
Journal:  World J Stem Cells       Date:  2014-01-26       Impact factor: 5.326

4.  Delay in diagnosis of primary intradural spinal cord tumors.

Authors:  David Segal; Zvi Lidar; Akiva Corn; Shlomi Constantini
Journal:  Surg Neurol Int       Date:  2012-05-14

5.  Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel.

Authors:  Betty M Tyler; Alia Hdeib; Justin Caplan; Federico G Legnani; Kirk D Fowers; Henry Brem; George Jallo; Gustavo Pradilla
Journal:  J Neurosurg Spine       Date:  2012-01

Review 6.  [Spinal tumors].

Authors:  F J Ahlhelm; P Fries; A Nabhan; W Reith
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

7.  Metastatic spine oncology: symptom-directed management.

Authors:  Lisa Marie Ruppert; Julia Reilly
Journal:  Neurooncol Pract       Date:  2020-11-18

Review 8.  Intramedullary lesions of the conus medullaris: differential diagnosis and surgical management.

Authors:  Florian H Ebner; Florian Roser; Marcus A Acioly; Wolfgang Schoeber; Marcos Tatagiba
Journal:  Neurosurg Rev       Date:  2008-09-27       Impact factor: 3.042

9.  Therapy for thoracic lumbar and sacral vertebrae tumors using total spondylectomy and spine reconstruction through posterior or combined anterior-posterior approaches.

Authors:  Pinglin Yang; Xijing He; Haopeng Li; Quanjin Zang; Guoyu Wang
Journal:  Oncol Lett       Date:  2016-01-19       Impact factor: 2.967

Review 10.  A patient with spinal metastasis from hepatocellular carcinoma discovered from neurological findings.

Authors:  Katsuyoshi Tamaki; Ichiro Shimizu; Mari Urata; Nao Kohno; Hiroshi Fukuno; Susumu Ito; Nobuya Sano
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.